Your browser doesn't support javascript.
loading
Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects.
Barret, Olivier; Alagille, David; Sanabria, Sandra; Comley, Robert A; Weimer, Robby M; Borroni, Edilio; Mintun, Mark; Seneca, Nicholas; Papin, Caroline; Morley, Thomas; Marek, Ken; Seibyl, John P; Tamagnan, Gilles D; Jennings, Danna.
Afiliação
  • Barret O; Molecular NeuroImaging LLC, New Haven, Connecticut obarret@mnimaging.com.
  • Alagille D; Molecular NeuroImaging LLC, New Haven, Connecticut.
  • Sanabria S; Genentech Research and Early Development, Genentech, South San Francisco, California.
  • Comley RA; Pharma Research and Early Development, F. Hoffmann-La Roche, Konzern-Hauptsitz, Basel, Switzerland.
  • Weimer RM; Genentech Research and Early Development, Genentech, South San Francisco, California.
  • Borroni E; Pharma Research and Early Development, F. Hoffmann-La Roche, Konzern-Hauptsitz, Basel, Switzerland.
  • Mintun M; Avid Radiopharmaceuticals, Philadelphia, Pennsylvania; and.
  • Seneca N; Product Development, F. Hoffmann-La Roche, Konzern-Hauptsitz, Basel, Switzerland.
  • Papin C; Molecular NeuroImaging LLC, New Haven, Connecticut.
  • Morley T; Molecular NeuroImaging LLC, New Haven, Connecticut.
  • Marek K; Molecular NeuroImaging LLC, New Haven, Connecticut.
  • Seibyl JP; Molecular NeuroImaging LLC, New Haven, Connecticut.
  • Tamagnan GD; Molecular NeuroImaging LLC, New Haven, Connecticut.
  • Jennings D; Molecular NeuroImaging LLC, New Haven, Connecticut.
J Nucl Med ; 58(7): 1124-1131, 2017 07.
Article em En | MEDLINE | ID: mdl-27908967
18F-AV-1451 is currently the most widely used of several experimental tau PET tracers. The objective of this study was to evaluate 18F-AV-1451 binding with full kinetic analysis using a metabolite-corrected arterial input function and to compare parameters derived from kinetic analysis with SUV ratio (SUVR) calculated over different imaging time intervals. Methods:18F-AV-1451 PET brain imaging was completed in 16 subjects: 4 young healthy volunteers (YHV), 4 aged healthy volunteers (AHV), and 8 Alzheimer disease (AD) subjects. Subjects were imaged for 3.5 h, with arterial blood samples obtained throughout. PET data were analyzed using plasma and reference tissue-based methods to estimate the distribution volume, binding potential (BPND), and SUVR. BPND and SUVR were calculated using the cerebellar cortex as a reference region and were compared across the different methods and across the 3 groups (YHV, AHV, and AD). Results: AD demonstrated increased 18F-AV-1451 retention compared with YHV and AHV based on both invasive and noninvasive analyses in cortical regions in which paired helical filament tau accumulation is expected in AD. A correlation of R2 > 0.93 was found between BPND (130 min) and SUVR-1 at all time intervals. Cortical SUVR curves reached a relative plateau around 1.0-1.2 for YHV and AHV by approximately 50 min, but increased in AD by up to approximately 20% at 110-130 min and approximately 30% at 160-180 min relative to 80-100 min. Distribution volume (130 min) was lower by 30%-35% in the YHV than AHV. Conclusion: Our data suggest that although 18F-AV-1451 SUVR curves do not reach a plateau and are still increasing in AD, an SUVR calculated over an imaging window of 80-100 min (as currently used in clinical studies) provides estimates of paired helical filament tau burden in good correlation with BPND, whereas SUVR sensitivity to regional cerebral blood changes needs further investigation.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Carbolinas / Proteínas tau / Tomografia por Emissão de Pósitrons / Doença de Alzheimer / Modelos Biológicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Nucl Med Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Carbolinas / Proteínas tau / Tomografia por Emissão de Pósitrons / Doença de Alzheimer / Modelos Biológicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Nucl Med Ano de publicação: 2017 Tipo de documento: Article